Chemotherapy for Ovarian Cancer in the Older Adult
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11864-009-0093-5.pdf
Reference20 articles.
1. Morgan R, Alvarez R, Armstrong DK, et al.: NCCN Clinical Practice Guidelines in Oncology—Ovarian Cancer v1.2008. 2008. http://www.nccn.org/professionals/physician_gls/PDF/ovarian.pdf
2. Bristow RE, Tomacruz RS, Armstrong DK, et al. (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20: 1248-59. doi: 10.1200/JCO.20.5.1248
3. Krivak TC, Darcy KM, Tian C, et al. (2008) Relationship between ERCC1 polymorphisms, disease progression, and survival in the Gynecologic Oncology Group Phase III Trial of intraperitoneal versus intravenous cisplatin and paclitaxel for stage III epithelial ovarian cancer. J Clin Oncol 26:3598-606. doi: 10.1200/JCO.2008.16.1323
4. Walsh CS, Ogawa S, Karahashi H, et al. (2008) ERCC5 is a novel biomarker of ovarian cancer prognosis. J Clin Oncol 26:2952-8. doi: 10.1200/JCO.2007.13.5806
5. Chan JK, Urban R, Cheung MK, et al. (2006) Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer 95:1314-20. doi: 10.1038/sj.bjc.6603457
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Treatment and survival outcomes from epithelial ovarian cancer in women aged 65 years or older;European Journal of Gynaecological Oncology;2020
2. MiRNA-802 suppresses proliferation and migration of epithelial ovarian cancer cells by targeting YWHAZ;Journal of Ovarian Research;2019-10-22
3. Elderly ovarian cancer patients: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO);European Journal of Cancer;2016-06
4. Management of Ovarian Cancer in Elderly;Reviews on Recent Clinical Trials;2015-10-28
5. The influence of comorbidity and comedication on grade III/IV toxicity and prior discontinuation of chemotherapy in recurrent ovarian cancer patients: An individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO);Gynecologic Oncology;2015-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3